Boris Johnson warns pharmaceutical companies may cease EU investments if vaccine export ban goes ahead
‘Arbitrary’ blockades are not ‘sensible’, warns prime minister
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Boris Johnson has warned that pharmaceutical companies may cease investments in the EU if Brussels imposes a vaccine export ban.
Mr Johnson’s comment came as the UK remained locked in a stand-off with the EU over Brussels demands for “reciprocity” in imports and exports of doses.
EU leaders will decide in a virtual meeting on Thursday whether to block the delivery of supplies which the UK insists are due to be sent to Britain under contracts signed last year.
Speaking to the House of Commons Liaison Committee, Mr Johnson said that “arbitrary” blockades of vaccines were not “sensible” and warned that any country imposing them would make itself less attractive as a destination for investment by pharmaceutical firms.
“I don’t think that blockades of either vaccines or of the ingredients for vaccines are sensible,” said the prime minister.
Read more:
“I think that the long-term damage done by blockades can be can be very considerable.”
And he added: “I would just gently point out to anybody considering a blockade or interruption of supply chains that companies may look at such actions and and draw conclusions about whether or not it is sensible to make future investments in countries where arbitrary blockades are imposed.”
EU leaders are furious that as many as 10m vaccine doses produced in continental Europe have been sent by AstraZeneca to the UK, while none have been exported from Britain to Europe.
The row comes at a time when EU vaccination programmes are lagging well behind the UK, with a new third wave of infections surging on the continent.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments